The AMOR study: A randomized, double-blinded trial of omeprazole versus ranitidine together with amoxycillin and metronidazole for eradication of Helicobacter pylori

European Journal of Gastroenterology and Hepatology

Volumn 13, Issue 6, 2001, Pages 685-691

  Ell, Christian ^a   Schoerner, Christoph ^b   Solbach, Werner ^c   Stolte, Manfred ^d   Vieth, Michael ^d   Ridl, Wolfgang ^e   Moser, Wolfgang ^e   Rabenstein, T ^a   Schneider, T ^a   Dumlein K J ^a   Zeus, J ^a   Schenk, J ^a   Fritsch, E V ^a   Janisch, H D ^a   Poeplau, W ^a   Meier, E ^a   Henning, W ^a   Lachmann, V ^a   Zeilmann, E ^a   Simon, T H ^a   Cyrus, B ^a   Burlefinger, R ^a   Ruckdeschel, P ^a   Fortelny, W ^a   Panijel, M ^a   Kretzschmar, W E ^a   Hofmann, J ^a   Schmied, P ^a   Schwemmer, W ^a   Nembach, H ^a   Grosskopf, R ^a   Lex, P ^a   Heptner, G ^a   Hagel, H J ^a   Borner N ^a   Topf, G ^a   Schreiber, H J ^a   Wiest, G ^a   Kerzel, W ^a   Thiemann, R ^a   Schutz E ^a   more..

^a HSK Wiesbaden ^*  (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY OF LÜBECK   (Germany)

^d Bayreuth Hospital   (Germany)

^e Biochemie Austria   (Australia)

Author keywords

Amoxycillin; Eradication; Helicobacter pylori; Metronidazole; Omeprazole; Ranitidine

Indexed keywords

AMOXICILLIN; METRONIDAZOLE; OMEPRAZOLE; RANITIDINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; DUODENUM ULCER; ERADICATION THERAPY; FEMALE; GASTRITIS; GRAM NEGATIVE INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH ANTRUM; ULCER HEALING;

ADOLESCENT; AGED; AGED, 80 AND OVER; AMOXICILLIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; DUODENAL ULCER; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; RANITIDINE; TREATMENT OUTCOME;

EID: 0034974207     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/00042737-200106000-00012     Document Type: Article

References (26)

1. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65-69.
2. The European Helicobacter pylori Study Group. Current European concepts in the management of Helicobacter pylori infection: The Maastricht Consensus Report. Gut 1997; 41: 8-13.
3. Lam SK, Talley NJ. Report of the 1997 Asia-Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol 1998; 13: 1-12.
4. Hentschel E, Brandstaetter G, Dragosics B, Hirschl AM, Nemec H, Schütze K. et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993; 328: 308-312.
5. Goh KL, Parasakthi N, Chuah SY, Toetsch M. Combination amoxycillin and metronidazole with famotidine in the eradication of Helicobacter pylori: A randomised, double-blind comparison of a three times daily and twice daily regimen. Eur J Gastroenterol Hepatol 1997; 9: 1091-1095.
6. Holtmann G, Layer P, Goebell H. Proton-pump inhibitors or H2-receptor antagonists for Helicobacter pylori eradication: A meta-analysis [letter]. Lancet 1996; 347: 763.
7. Holtmann G, Layer P, Goebell H. Sind Protonenpumpeninhibitoren den H2-Rezeptorantagonisten im Rahmen der H. pylori-Eradikationstherapie uberlegen? Metaanalyse vorliegender Parallelgruppenvergleiche. [Are proton pump inhibitors superior to H2 receptor antagonists in H. pylori eradication therapy? Meta-analysis of parallel-group studies]. Z Gastroenterol 1996; 34: 267-272.
8. Bell GD, Powell KU, Burridge SM, Bowden A, Atoyebi W, Bolton G. et al. Rapid eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 1995; 9: 41-46.
9. Bell GD, Powell KU, Burridge SM, Bowden A, Rameh B, Bolton G. et al. Helicobacter pylori eradication: Efficacy and side effect profile of a combination of omeprazole, amoxicillin and metronidazole compared with four alternative regimens. QJM 1993; 86: 743-750.
10. Goh KL, Peh SC, Parasakthi N, Wong NW, Tan KK, Lo YL. et al. Omeprazole 40 mg o.m. combined with amoxycillin alone or with amoxycillin and metronidazole in the eradication of Helicobacter pylori. Am J Gastroenterol 1994; 89: 1789-1792.
11. Bell GD, Bate CM, Axon ATR, Tildesley G, Kerr GD, Grun JRB. et al. Addition of metronidazole to omeprazole/amoxycillin dual therapy increases the rate of Helicobacter pylori eradication: A double-blind, randomised trial. Aliment Pharmacol Ther 1995; 9: 513-520.
12. Grand SM, Langtry HD, Brogden RN. Ranitidine: An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases. Drugs 1989; 37: 801-870.
13. Lazzaroni M, Porro GB. Treatment of peptic ulcers in the elderly. Drugs Aging 1996; 4: 251-261.
14. Walsh JH, Peterson WL. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N Engl J Med 1995; 333: 984-991.
15. Glupczinski Y. In vitro susceptibility testing of Helicobacter pylori to antimicrobial agents: Basis for treatment or microbiologists’ obsession? Zentralbl Bakteriol 1993; 280: 227-238.
16. Grayson ML, Eliopoulos GM, Ferraro MJ, Moellering RC. et al. Effect of varying pH on the susceptibility of Campylobacter pylori to antimicrobial agents. Eur J Clin Microbiol Infect Dis 1989; 8: 888-889.
17. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis: The updated Sydney System (International Workshop on the Histopathology of Gastritis, Houston 1994). Am J Surg Pathol 1996; 20: 1161-1181.
18. Stolte M, Stadelmann O, Bethke B, Burkard G. Relationship between the degree of Helicobacter pylori colonisation and the degree and activity of gastritis, surface epithelial degeneration and mucus secretion. Z Gastroenterol 1995; 33: 89-93.
19. Penston JG, McColl KEL. Eradication of Helicobacter pylori: An objective assessment of current therapies. Br J Clin Pharmacol 1997; 43: 223-243.
20. Gschwantler M, Dragosics B, Schutze K, Wurzer H, Hirschl AM, Pasching E. et al. Famotidine versus omeprazole in combination with clarithromycin and metronidazole for eradication of Helicobacter pylori- a randomized, controlled trial. Aliment Pharmacol Ther 1999; 13: 1063-1069.
21. Grigoriev PY, Zoseeva OV, Jakovenko AV, Jakovenko EP. Zantac (ranitidine) antimicrobial therapy vs. omeprazole antimicrobial therapy for Helicobacter pylori (HP) associated peptic ulcer (PU). Am J Gastroenterol 1994; 89: 1392.
22. Lanzon-Miller S, Pounder RE, Hamilton MR, Ball S, Chronos NAF, Raymond F. et al. Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole. Aliment Pharmacol Ther 1987; 1: 239-251.
23. Goddard AF, Jessa MJ, Barret DA, Shaw N, Idstroem JP, Cederberg C. et al. Effect of omeprazole on the distribution of metronidazole, amoxycillin and clarithromycin in human gastric juice. Gastroenterology 1996; 111: 358-367.
24. Van Zanten SJO, Goldie J, Hollingsworth J, Silletti C, Richardson H, Hunt RH. et al. Secretion of intravenously administered antibiotics in gastric juice: Implications for management of Helicobacter pylori. J Clin Pathol 1992; 45: 225-227.
25. Lind T, Mégraud F, Unge P, Bayerdoerffer E, O’Morain C, Spiller R. et al. The MACH 2 Study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. Gastroenterology 1999; 116: 248-253.
26. De Boer W, Driessen W, Jansz A, Tytgat G. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 1995; 345: 817-820.